Business Context and Reporting Period
This Form 8-K filing by Crane Co. (Crane NXT, Co.) was submitted on October 22, 2018. The report primarily addresses the Company's results of operations for the quarter ended September 30, 2018, and provides a detailed update on asbestos liability claims and costs. The financial results are referenced via an attached press release (Exhibit 99.1), while the text focuses extensively on litigation status and actuarial liability estimates.
Key Financial Metrics: Asbestos Liability and Costs
The filing provides specific data regarding asbestos-related claims, costs incurred, and cash flows, though general revenue and profit figures are not detailed in the text provided.
- Pending Claims: As of September 30, 2018, there were 29,323 pending asbestos claims (down from 32,075 in the prior year).
- Costs Incurred (Nine Months Ended Sept 30, 2018):
- Total costs incurred: $69.7 million (down from $75.5 million in 2017).
- Settlement/indemnity costs: $49.6 million.
- Defense costs: $20.1 million.
- Cash Payments (Nine Months Ended Sept 30, 2018):
- Total pre-tax cash payments (net of insurance receipts): $46.4 million (compared to $46.8 million in 2017).
- Settlement payments: $46.0 million.
- Defense payments: $17.7 million.
- Insurance receipts: $17.3 million.
- Liability Estimate: The recorded asbestos liability was $542 million as of September 30, 2018 (down from $696 million as of December 31, 2016). The current portion expected to be paid within 12 months is $85 million.
- Insurance Recoveries: An asset of $98 million was recorded as of September 30, 2018, representing probable insurance reimbursements.
Material Changes and Litigation Updates
The filing details significant developments in specific high-profile asbestos cases and overall claim trends:
- Claim Volume: New claims filed in the three months ended September 30, 2018, were 574, compared to 667 in the same period in 2017. Dismissals increased significantly to 997 in the quarter, compared to 294 in the prior year.
- Richard DeLisle Claim: On October 15, 2018, the Supreme Court of Florida reversed a lower court's decision in favor of the Company, reinstating a trial court judgment of $1.3 million. The Company is considering further appellate options.
- George Coulbourn Claim: The Ninth Circuit Court of Appeals affirmed a $6.8 million judgment against the Company on March 29, 2018. The Company settled this matter, with the cost reflected in the second quarter 2018 indemnity amount.
- James Poage Claim: The Supreme Court of the United States denied review of a $10.8 million judgment on March 26, 2018. The Company settled this matter, reflected in the second quarter 2018 indemnity amount.
- James Nelson Claim: A case set for a new trial in April 2018 was settled, with the amount reflected in the second quarter 2018 indemnity amount.
Outlook, Risks, and Management Commentary
Management maintains that the current liability estimate through 2059 is reasonable based on stabilized mesothelioma claim filings, favorable case law trends, and legislative restrictions in key jurisdictions. No change to the liability estimate was deemed necessary for the period ended September 30, 2018.
- Forecast Period: The liability estimate covers claims projected through 2059. Cash payments are expected to continue for years beyond this date due to the lag between filing and resolution.
- Key Risk Factors: The estimate is subject to significant uncertainties, including the number of new mesothelioma claims, average settlement costs, dismissal rates, and defense costs. Adverse verdicts, legislative changes, or shifts in case law could materially alter the liability.
- Insurance Uncertainty: While the Company has "coverage-in-place" agreements with most excess insurers, the timing and amount of reimbursements vary. The estimated reimbursement rate is approximately 21% of the total liability.
- Unusual Items: The filing notes that cash payments often lag incurred costs by several months, leading to potential quarterly fluctuations in cash flow.
Investor Verification Checklist
- Verify the full quarterly financial results (Revenue, Net Income, EPS) in the attached Exhibit 99.1 press release, as these figures are not present in the 8-K text.
- Monitor the status of the Richard DeLisle appeal in Florida, as the Supreme Court reinstated a $1.3 million judgment against the Company.
- Review the trend of new mesothelioma claims versus dismissals to assess the stability of the $542 million liability reserve.
- Confirm the status of insurance coverage agreements, particularly with the one remaining solvent excess insurer that has not fully settled its obligations.
- Assess the impact of the $85 million current portion of the asbestos liability on the Company's short-term liquidity and cash flow projections.